Serum matrix metalloproteinase activity relating to cartilage destruction in rheumatoid arthritis

APLAR Journal of Rheumatology

Volumn 8, Issue 3, 2005, Pages 213-219

  Takemura, Tatsuya ^a   Kanbe, Katsuaki ^b   Takeuchi, Kimihiko ^a   Inoue, Kazuhiko ^b   Takagishi, Kenji ^a  

^a GUNMA UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

MMP 13; MMP 9; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; COLLAGENASE 3; GELATINASE B; MATRIX METALLOPROTEINASE; RHEUMATOID FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE DEGENERATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENZYME ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SYNOVIUM;

EID: 29144505150     PISSN: 02190494     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-8077.2005.00149.x     Document Type: Article

References (35)

1. Fearon U, Reece R, Smith J, Emery P, Veale DJ (1999) Synovial cytokine and growth factor regulation of MMPs/ TIMPs: implications for erosions and angiogenesis in early rheumatoid and psoriatic arthritis patients. Ann N Y Acad Sci 878, 619-21.
2. Konttinen YT, Ainola M, Valleala H, et al. (1999) Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 58, 691-7.
3. Altmann RD, Gray R (1983) Diagnostic and therapeutic uses of the arthroscope in rheumatoid arthritis and osteoarthritis. Am J Med 75, 50-5.
4. Roch-Bras F, Daures JP, Legouffe MC, Sany J, Combe B (2002) Treatment of chronic knee synovitis with arthroscopic synovectomy: long-term results. J Reumatol 29, 1171-5.
5. Horiuchi K, Momohara S, Tomatsu T, Inoue K, Toyama Y (2002) Arthroscopic synovectomy of the elbow in rheumatoid arthritis. J Bone Joint Surg Am 84, 342-7.
6. Matsui N, Moriya H, Kitahara H (1979) The use of arthroscopy for follow-up in knee joint surgery. Orthop Clin North Am 10, 697-708.
7. Arnett FC, Edworthy SM, Bloch DA, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31, 315-24.
8. Steinbrocker O, Traeger CH, Battermann RC (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140, 659-62.
9. Larsen A (1995) How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies. J Rheumatol 22, 1974-5.
10. Konttinen YT, Salo T, Hanemaaijer R, et al. (1999) Collagenase-3 (MMP-13) and its active in rheumatoid arthritis: localization in the pannus-hard tissue junction and inhibition by alendronate. Matrix Biol 18, 401-12.
11. Yoshihara Y, Nakamura H, Obata K, et al. (2000) Matrix metalloproteases and tissue inhibitors of metalloproteases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 59, 455-61.
12. Fraser A, Fearon U, Reece R, Emery P, Veale DJ (2001) Matrix Metalloproteinase 9, apoptosis, and vascular morphology in early arthritis. Arthritis Rheumatism 44, 2024-8.
13. Moldovan F, Pelletier JP, Hambor J, Cloutier JM, Martel-Pelletier J (1997) Collagenase-3 (matrixmetalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: in vitro mimicking effect by transforming growth factor beta. Arthritis Rheum 40, 1653-61.
14. Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik B, Skowronski J, Chwiecko J (2002) Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis. Rheumatology 41, 78-87.
15. Omura K, Takahashi M, Omura T, et al. (2002) Changes in the concentration of plasma matrix metalloproteinase (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) after total joint replacement in patients with arthritis. Clin Rheumatol 21, 488-92.
16. Ishiguro N, Ito T, Oguchi T, et al. (2001) Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis. Arthritis Rheum 44, 2503-11.
17. Lindy O, Kontiinen YT, Sorsa T, Santavirta S, Ceponis A, López-Otin C (1997) Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum 40, 1391-9.
18. Imai S, Konttinen YT, Jumppanen M, et al. (1998) High level of expression of colagenase-3 (MMP-13) in pathological condition associated to a forein body reaction. J Bone Joint Surg 80, 701-10.
19. Uria JA, Stahle-Backdahl M, Seiki M, Fueyo A, López-Otín C (1997) Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epitherial cell interaction. Cancer Res 57, 4882-8.
20. Kanbe K, Takagishi K, Chen Q (2002) Stimulation of matrix metalloprotease 3 release from human chondrocytes by the interaction of stromal cell-derived factor 1 and CXC chemokine receptor 4. Arthritis Rheum 46, 130-7.
21. Katsche KJ Jr, Rottman JB, Ruth JH, et al. (2001) Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum 44, 1022-32.
22. Knäuper V, López-Otin C, Smith B, Knight G, Murphy G (1996) Biochemical characterization of human collagenase-3. J Biol Chem 271, 1544-50.
23. Mitchell PG, Magna HA, Reeves LM, et al. (1996) Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 97, 761-8.
24. Billinghurst RC, Dahlberg L, Ionescu M, et. al. (1997) Enhanced cleavage of type II collagen by collagenase in osteoarthritic articular cartilage. J Clin Invest 99, 1534-45.
25. Knäuper V, Cowell S, Smith B, et al. (1997) The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity and tissue inhibitor of metalloproteinase interaction. J Biol Chem 272, 7608-16.
26. Fosang AJ, Last K, Knäuper V, Murphy G, Neame PJ (1996) Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett 380, 17-20.
27. Reboul P, Pelletier JP, Tardif G, et al. (1996) The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. J Clin Invest 97, 2011-9.
28. MacNaul KL, Chartrain N, Lark M, Tocci MJ, Hutchinson NI (1990) Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinase-1 in rheumatoid human synovial fibroblast. J Biol Chem 265, 17238-45.
29. Gearing AJ, Beckett P, Christodoulou M, et al. (1994) Processing of tumor necrosis factor-α precursor by metalloproteinases. Nature 370, 555-7.
30. Itoh A, Mukaiyama A, Itoh Y, et al. (1996) Degradation of interleukin 1 by matrix metalloproteinases. J Biol Chem 271, 14657-60.
31. Maeda S, Sawai T, Uzuki M, et al. (1995) Determination of interstitial collagenase (MMP-1) in patients with rheumatoid arthritis. Ann Rheum Dis 54, 970-5.
32. Ahrens D, Koch AE, Pope RM, Stein-Picarella M, Niedbala MJ (1996) Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthrritis Rheum 39, 1576-87.
33. Keyszer G, Lambiri I, Nagel R, et al. (1999) Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. J Rheumatol 26, 251-8.
34. Goldbach-Mansky R, Lee JM, Hoxworth JM, et al. (2000) Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis. Arthritis Res 2, 145-53.
35. Westhoff CS, Freudiger D, Petrow P, et al. (1999) Characterization of collagenase 3 (matrix metaloproteinase 13) messenger RNA expression in the synovial membrane and synovial fibroblasts of patients with rheumatoid arthritis. Arthritis Rheum 42, 1517-27.